Sutro Biopharma Inc sell Bank of America Co.
Start price
14.03.25
/
50%
€0.85
Target price
14.03.26
€0.92
Performance (%)
-26.12%
Price
02.12.25
€0.62
Summary
This prediction is currently active. The price of Sutro Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.12%. This prediction currently runs until 14.03.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sutro Biopharma Inc | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $1.00 price target on the stock, down previously from $11.00.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€0.77
19.05.25
19.05.25
€0.72
19.05.26
19.05.26
-18.92%
02.12.25
02.12.25
